Effect of Marzanjosh (unani medicine) on Metabolic syndrome
Phase 2
- Conditions
- Health Condition 1: E88- Other and unspecified metabolic disorders
- Registration Number
- CTRI/2023/06/053618
- Lead Sponsor
- ational Institute of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
A)According to NCEP ATP • Criteria Any three of the following
1)Waist circumference >= 90 cm in men and >= 80 cm in females
2)Fasting Plasma Glucose Level >= 100 mg/dl or (diagnosed patient with type 2 Diabetes)
3)HDL level <= 40 mg/dl in males, < 50 mg/dl in females or (diagnosed patients with dyslipidemia).
4)Triglycerides >= 150 mg/dl or (diagnosed patients with dyslipidemia).
5)Blood pressure > 130/85 mmHg, or (diagnosed patient with hypertension)
Exclusion Criteria
1.Pregnant and lactating women
2.Patients having cardiac, liver and renal disorders
3.Patients of secondary obesity
4.Diabetes mellitus requiring the use of insulin.
5.BMI > 35 kg/m2
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effect on metabolic control: <br/ ><br>1.FBS <br/ ><br>2.Waist Circumference <br/ ><br>3.Systolic and Diastolic Blood pressure <br/ ><br>4.HDL <br/ ><br>5.Triglycerides <br/ ><br>Timepoint: 8 weeks
- Secondary Outcome Measures
Name Time Method 1. Assessment of Quality-of-Life, World Health Organization Quality of life questionnaire (WHOQOL-BREF <br/ ><br>2. Body Mass Index (BMI) <br/ ><br>Timepoint: 8 weeks